Integrated Diagnostics (LON:IDHC) Share Price Passes Below Fifty Day Moving Average – What’s Next?

Integrated Diagnostics Holdings plc (LON:IDHC)’s share price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 0.57 and traded as low as GBX 0.50. Integrated Diagnostics shares last traded at GBX 0.50, with a volume of 51,611 shares.

Integrated Diagnostics Stock Up 4.8%

The firm has a market cap of £3.06 million, a price-to-earnings ratio of 0.00, a price-to-earnings-growth ratio of 7.65 and a beta of 0.38. The company has a current ratio of 1.53, a quick ratio of 0.75 and a debt-to-equity ratio of 43.40. The stock has a 50-day moving average of GBX 0.57 and a 200-day moving average of GBX 0.61.

About Integrated Diagnostics

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.